About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Ataxia
Patient Information:
Treatment: Nerve Growth Factor Therapy, Neurovascular Improvement Therapy, Traditional Chinese Medicine (TCM), and Rehabilitation Training
Medical History:
Miguel Angel was admitted to Puhua International Hospital on April 25th, 2011, for treatment of Spinocerebellar Ataxia (SCA). His condition began deteriorating at the age of 43, five years prior to admission, with increasing difficulty in walking and balance issues. Over time, his speech became slurred, making communication challenging. Due to his progressive symptoms, Miguel's daily life was significantly impacted, causing him emotional distress.
Medical Condition before Nerve Growth Factor Therapy for Spinocerebellar Ataxia (SCA):
Upon arrival at Puhua Hospital:
Treatment Course:
Miguel received Nerve Growth Factor Therapy, Neurovascular Improvement Therapy (targeting blood circulation and nutrient delivery to the neural system), Traditional Chinese Medicine (TCM), and comprehensive rehabilitation training.
Post-Treatment Updates:
Following completion of the treatment protocol:
Family feedback: The family described perceived changes after a programme of several interventions. A personal recommendation does not establish treatment efficacy or suitability for other people with ataxia.
Scan to connectSelect your language
